Bisphenol A substitutes and obesity in US adults: analysis of a population-based, cross-sectional study

The Lancet Planetary Health

Volumn 1, Issue 3, 2017, Pages e114-e122

  Liu, Buyun ^a   Lehmler, Hans Joachim ^a   Sun, Yangbo ^a   Xu, Guifeng ^a   Liu, Yuewei ^b   Zong, Geng ^c   Sun, Qi ^c,d   Hu, Frank B ^c,d   Wallace, Robert B ^a   Bao, Wei ^a  

^a UNIVERSITY OF IOWA   (United States)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BISPHENOL F; BISPHENOL S; CREATININE; PHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; ODDS RATIO; POPULATION RESEARCH; SOCIAL STATUS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; UNITED STATES; URINE LEVEL; WAIST CIRCUMFERENCE;

EID: 85043772417     PISSN: None     EISSN: 25425196     Source Type: Journal    
DOI: 10.1016/S2542-5196(17)30049-9     Document Type: Article

References (34)

1. Malik, VS, Willett, WC, Hu, FB, Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 9 (2013), 13–27.
2. Heindel, JJ, Blumberg, B, Cave, M, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol 68 (2017), 3–33.
3. Heindel, JJ, Newbold, R, Schug, TT, Endocrine disruptors and obesity. Nat Rev Endocrinol 11 (2015), 653–661.
4. Rochester, JR, Bisphenol A and human health: a review of the literature. Reprod Toxicol 42 (2013), 132–155.
5. Michalowicz, J., Bisphenol A—sources, toxicity and biotransformation. Environ Toxicol Pharmacol 37 (2014), 738–758.
6. Calafat, AM, Kuklenyik, Z, Reidy, JA, Caudill, SP, Ekong, J, Needham, LL, Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113 (2005), 391–395.
7. Gore, AC, Chappell, VA, Fenton, SE, et al. EDC-2: The Endocrine Society's Second Scientific Statement on endocrine-disrupting chemicals. Endocr Rev 36 (2015), E1–150.
8. Liao, C, Kannan, K, A survey of alkylphenols, bisphenols, and triclosan in personal care products from China and the United States. Arch Environ Contam Toxicol 67 (2014), 50–59.
9. Liao, CY, Liu, F, Kannan, K, Bisphenol S, a new bisphenol analogue, in paper products and currency bills and its association with bisphenol A residues. Environ Sci Technol 46 (2012), 6515–6522.
10. Liao, C, Kannan, K, A survey of bisphenol A and other bisphenol analogues in foodstuffs from nine cities in China. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 31 (2014), 319–329.
11. Ye, X, Wong, LY, Kramer, J, Zhou, X, Jia, T, Calafat, AM, Urinary concentrations of bisphenol A and three other bisphenols in convenience samples of U.S. adults during 2000–2014. Environ Sci Technol 49 (2015), 11834–11839.
12. Rochester, JR, Bolden, AL, Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Persp 123 (2015), 643–650.
13. National Center for Health Statistics, Centers for Disease Control and Prevention, National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes/about_nhanes.htm (accessed Oct 18, 2016).
14. Barr, DB, Wilder, LC, Caudill, SP, Gonzalez, AJ, Needham, LL, Pirkle, JL, Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113 (2005), 192–200.
15. Johnson, CL, Paulose-Ram, R, Ogden, CL, et al. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat 2 2 (2013), 1–24.
16. WHO. Global Physical Activity Questionnaire (GPAQ) analysis guide, 2014, World Health Organization, Geneva.
17. Feng, Y, Jiao, Z, Shi, J, Li, M, Guo, Q, Shao, B, Effects of bisphenol analogues on steroidogenic gene expression and hormone synthesis in H295R cells. Chemosphere 147 (2016), 9–19.
18. Kidani, T, Kamei, S, Miyawaki, J, Aizawa, J, Sakayama, K, Masuno, H, Bisphenol A downregulates Akt signaling and inhibits adiponectin production and secretion in 3T3-L1 adipocytes. J Atheroscler Thromb 17 (2010), 834–843.
19. Boucher, JG, Ahmed, S, Atlas, E, Bisphenol S induces adipogenesis in primary human preadipocytes from female donors. Endocrinology 157 (2016), 1397–1407.
20. Zheng, S, Shi, JC, Hu, JY, Hu, WX, Zhang, J, Shao, B, Chlorination of bisphenol F and the estrogenic and peroxisome proliferator-activated receptor gamma effects of its disinfection byproducts. Water Res 107 (2016), 1–10.
21. Janesick, A, Blumberg, B, Minireview: PPAR gamma as the target of obesogens. J Steroid Biochem 127 (2011), 4–8.
22. Boucher, JG, Gagne, R, Rowan-Carroll, A, Boudreau, A, Yauk, CL, Atlas, E, Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One, 11, 2016, e0163318.
23. Ahmed, S, Atlas, E, Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation. Int J Obesity 40 (2016), 1566–1573.
24. Helies-Toussaint, C, Peyre, L, Costanzo, C, Chagnon, MC, Rahmani, R, Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study. Toxicol Appl Pharm 280 (2014), 224–235.
25. Ranciere, F, Lyons, JG, Loh, VHY, et al. Bisphenol A and the risk of cardiometabolic disorders: a systematic review with meta-analysis of the epidemiological evidence. Environ Health, 14, 2015, 46.
26. Hugo, ER, Brandebourg, TD, Woo, JG, Loftus, J, Alexander, JW, Ben-Jonathan, N, Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Persp 116 (2008), 1642–1647.
27. Riu, A, Grimaldi, M, le Maire, A, et al. Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A. Environ Health Persp 119 (2011), 1227–1232.
28. Anderson, OS, Nahar, MS, Faulk, C, et al. Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A. Environ Mol Mutagen 53 (2012), 334–342.
29. Singh, S, Li, SS, Epigenetic effects of environmental chemicals bisphenol A and phthalates. Int J Mol Sci 13 (2012), 10143–10153.
30. Vandenberg, LN, Colborn, T, Hayes, TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33 (2012), 378–455.
31. Boucher, JG, Boudreau, A, Ahmed, S, Atlas, E, In vitro effects of bisphenol A beta-D-glucuronide (BPA-G) on adipogenesis in human and murine preadipocytes. Environ Health Perspect 123 (2015), 1287–1293.
32. Trasande, L, Attina, TM, Blustein, J, Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 308 (2012), 1113–1121.
33. Usman, A, Ahmad, M, From BPA to its analogues: is it a safe journey?. Chemosphere 158 (2016), 131–142.
34. Ye, X, Wong, LY, Bishop, AM, Calafat, AM, Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect 119 (2011), 983–988.